Actas dermo-sifiliograficas最新文献_第10页

CO2 Laser Ablation for Multiple Miliary Osteoma Cutis: Diagnostic and Procedural Role of the “Spark Sign” Co₂激光消融治疗多发性军事性骨瘤：“火花征”的诊断和治疗作用。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104502

P. López Sanz , D. Barco

引用次数: 0

Cutaneous Squamous Cell Carcinoma While on Vismodegib Therapy for Locally Advanced Basal Cell Carcinoma 皮肤鳞状细胞癌，而维莫替吉治疗局部晚期基底细胞癌。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104500

B. Sánchez Lafuente , P.J. Vera García , P. Cerezuela Fuentes

引用次数: 0

Monitoring the Effectiveness of Noninvasive or Minimally Invasive Therapies for Nonmelanocytic Lesions Using Reflectance Confocal Microscopy: A Systematic Review 利用反射共聚焦显微镜监测非黑素细胞病变的无创或微创治疗的有效性：一项系统综述。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104492

J.M. Villa-Gonzalez , M.R. Gonzalez-Hermosa , M. Ardigò , S. Gonzalez

{"title":"Monitoring the Effectiveness of Noninvasive or Minimally Invasive Therapies for Nonmelanocytic Lesions Using Reflectance Confocal Microscopy: A Systematic Review","authors":"J.M. Villa-Gonzalez , M.R. Gonzalez-Hermosa , M. Ardigò , S. Gonzalez","doi":"10.1016/j.ad.2025.104492","DOIUrl":"10.1016/j.ad.2025.104492","url":null,"abstract":"<div><div>In vivo reflectance confocal microscopy (RCM) enables monitoring of non-melanocytic skin cancers (NMSC) treated with non-invasive or minimally invasive therapies. This systematic review analyzed studies on NMSC treated with these therapies and monitored by RCM. A total of 56 articles were included, with 40 focusing on squamous conditions, such as actinic keratosis and squamous cell carcinoma, 15 on basal cell carcinoma (BCC), and 1 on extramammary Paget's disease. Evaluated therapies included ablative laser, cryosurgery, photodynamic therapy, 5-fluorouracil, imiquimod, and tirbanibulin, among others. RCM demonstrated complete response in squamous conditions with normalization of the honeycomb pattern and reduction of scaling and parakeratosis, frequently allowing for detection of subclinical malignancy. In BCC, RCM showed complete response as disappearance of tumor islands. RCM allows treatment optimization and early monitoring, even when inflammation hinders clinical assessment. It is recommended that RCM evaluations be performed starting at least 1 month after treatment for squamous conditions and 3 months for BCC.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 1","pages":"Article 104492"},"PeriodicalIF":2.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145686806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Second-degree Burns: Contemporary Management, Evidence Gaps, and Practical Proposals 二度烧伤：当代管理，证据差距，和实际建议。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104503

J. Ugedo Alzaga , E. Conde-Montero

引用次数: 0

Tralokinumab Effectiveness in Moderate-to-severe Atopic Dermatitis With Palmoplantar Eczema 曲洛单抗治疗中重度特应性皮炎伴掌跖湿疹的疗效。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104494

J.J. Domínguez-Cruz , F.J. Navarro-Triviño , M. Galán-Gutiérrez , J.J. Pereyra-Rodríguez , J.C. Armario-Hita , R. Ruiz-Villaverde

引用次数: 0

Facial Lesions Transmission in the Context of Sexual Relations 性行为中面部损伤的传播。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104501

M. Cotarelo Hernández , T. Puerta López , J.A. Pérez-García

引用次数: 0

Arborizing Vessels and Whitish Shiny Structures on a Salmon-colored Background: A Diagnostic Framework 在鲑鱼色的背景上，树突状的血管和白色闪亮的结构：一种诊断框架。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104506

A. Barrutia-Etxebarria, R.M. Escribano De La Torre, J. Gimeno Castillo

引用次数: 0

Long-Term Real-World Persistence of Guselkumab in Patients With Moderate-to-Severe Psoriasis guelkumab在中重度牛皮癣患者中的长期实际持续治疗。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104493

J. Borrás-Blasco , R. Alcala , A. Valcuende-Rosique , S. Cornejo

引用次数: 0

Tranexamic Acid in Cutaneous Oncologic and Cosmetic Surgery: A Comprehensive Narrative Review 氨甲环酸在皮肤肿瘤学和整容手术中的应用综述。

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-02 DOI: 10.1016/j.ad.2025.104485

P. Balado-Simó , S. Gomez-Martinez , D. Morgado-Carrasco

引用次数: 0

Evaluation of the Risk of Psoriatic Arthritis in Patients With Psoriasis Undergoing Biological Treatment. Global Population Study (TRINETX) 银屑病生物治疗患者银屑病关节炎风险评价全球人口研究（TRINETX）

IF 2.8

Actas dermo-sifiliograficas Pub Date : 2026-01-01 Epub Date: 2025-12-03 DOI: 10.1016/j.ad.2025.104488

R. Rivera-Diaz , B. Joven , G. Hernandez-Ibarburu , C. García-Donoso , J.L. Pablos , P.L. Ortiz-Romero

{"title":"Evaluation of the Risk of Psoriatic Arthritis in Patients With Psoriasis Undergoing Biological Treatment. Global Population Study (TRINETX)","authors":"R. Rivera-Diaz , B. Joven , G. Hernandez-Ibarburu , C. García-Donoso , J.L. Pablos , P.L. Ortiz-Romero","doi":"10.1016/j.ad.2025.104488","DOIUrl":"10.1016/j.ad.2025.104488","url":null,"abstract":"<div><h3>Introduction</h3><div>Psoriatic arthritis (PsA) is an inflammatory condition associated with psoriasis (PsO), with variable prevalence ranging from 6% to 42%. Despite the known link between PsO and PsA, reliable biomarkers for predicting PsA onset remain elusive. Recent research has identified risk determinants including obesity, onychopathy, PsO severity, and familial predisposition. Detecting PsO patients at risk of developing PsA is crucial given the disparity in treatment efficacy post-PsA establishment.</div></div><div><h3>Objective</h3><div>This study evaluates the rate of PsA among PsO patients undergoing targeted biologic therapy as first- or second-line therapy.</div></div><div><h3>Material and methods</h3><div>We conducted a retrospective cohort study utilizing TriNetX database and identified PsO patients receiving biologic therapy. Propensity score matching was applied to adjust for potential confounders. Patients were followed for 5 years, and the incidence rate of PsA was determined. Statistical analyses were performed to estimate relative risks and hazard ratios.</div></div><div><h3>Results</h3><div>Among 1,175,000 PsO patients, 41,990 received first-line biologic therapy. Following matching, patients initiating IL12/23i or IL23i exhibited a lower PsA incidence rate vs TNFi. Second-line IL12/23i and IL23i treatment also showed a lower PsA risk vs TNFi. IL17i did not significantly differ from TNFi in PsA risk.</div></div><div><h3>Conclusion</h3><div>This study highlights differential PsA risk among PsO patients on biologic therapy, suggesting potential benefits of IL12/23i and IL23i in PsA prevention. Prospective studies are needed to confirm these findings and optimize PsA prevention strategies.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 1","pages":"Article 104488"},"PeriodicalIF":2.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145686755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0